Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphorylated microtubule-associated protein tau at threonine 217 (p-tau217) is a specific post-translationally modified form of the tau protein, where the amino acid threonine at position 217 is phosphorylated. It serves as a biomarker in neurodegenerative diseases, particularly Alzheimer’s disease, correlating strongly with disease pathology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphorylated microtubule-associated protein tau at threonine 217 (p-tau217).